EBV-transformed lymphoblastoid cell lines down-regulate ebna in parallel with secretory differentiation
- 14 March 1987
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 39 (3) , 404-408
- https://doi.org/10.1002/ijc.2910390322
Abstract
Four monoclonal and one polyclonal lymphoblastoid cell line (LCL) were studied with regard to cytoplasmic immunoglobulin (clg) expression, presence of the Epstein‐Barr virus (EBV)‐determined nuclear antigen (EBNA) and DNA synthesis. Each line was found to consist of two subpopulations, with only minimal overlap. Proliferating, EBNA‐positive, clg‐negative cells formed the majority. The minority were EBNA‐negative, contained abundant clg and were largely non‐proliferating. This suggests the continuous occurrence of a maturation process within each LCL. The concomitant downregulation of EBNA raises the interesting question whether continued synthesis of the nuclear antigen is incompatible with differentiation for epigenetic reasons, or, alternatively, whether differentiation takes place when the viral genomes are suppressed or lost.This publication has 32 references indexed in Scilit:
- Progenitor and pre‐B lymphocytes transformed by epstein‐barr virusInternational Journal of Cancer, 1987
- Expression of B‐cell‐specific markers in different burkitt lymphoma subgroupsInternational Journal of Cancer, 1987
- An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.Proceedings of the National Academy of Sciences, 1986
- Production of Human Monoclonal Antibodies Using Epstein—Barr VirusPublished by Springer Nature ,1985
- Surface antigen expression by a human B-lymphoblastoid cell line treated with ‘differentiation’ inducers, dimethylsulfoxide and tetradecanoylphorbol acetateLeukemia Research, 1985
- Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.Proceedings of the National Academy of Sciences, 1984
- Epstein-Barr virus susceptibility of normal human B lymphocyte populations.The Journal of Experimental Medicine, 1984
- Production of Human Monoclonal Antibody to X31 Influenza Virus NucleoproteinJournal of General Virology, 1983
- Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA ReplicationScience, 1982
- Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.The Journal of Experimental Medicine, 1982